Mohammad Atiq to Antineoplastic Agents
This is a "connection" page, showing publications Mohammad Atiq has written about Antineoplastic Agents.
Connection Strength
0.106
-
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors. Clin Cancer Res. 2021 03 15; 27(6):1792-1806.
Score: 0.086
-
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer. Mol Oncol. 2020 08; 14(8):1881-1897.
Score: 0.021